Skip to main content

Table 1 Demographics, clinical, and laboratory findings (group 1 vs group 2)

From: Effect of COVID-19 on Kawasaki Disease: Decrease Age of Onset and Increase Skin Manifestation

Characteristics

Total (n = 76)

Group 1

(n = 32)

Group 2

(n = 44)

P value

Estimated Power (%)

Age

5.03

4.38

5.50

0.044

29

Male%

60% (n = 46)

65%

(n = 21)

56%

(n = 25)

0.438

8

Hospital course (days)

4.47

5.13

4.00

0.555

30

Conjunctivitis

38 (50%)

14 (43.8%)

24 (52.2%)

0.353

7

Lymphadenopathy

27 (36%)

9 (28.1%)

18 (39.1%)

0.250

11

Oral mucosa or lips changes

44 (58%)

16 (50%)

28 (60%)

0.160

9.1

Rash

47 (62%)

19 (59%)

28 (60.1%)

0.706

3.5

Extremity changes

44 (58%)

19 (59%)

25 (54.3%)

0.824

3.7

Abnormal echocardiography findings (regarding coronary arteries)

33 (43%)

11 (34%)

12 (26%)

0.534

7.4

ESR(mm/h)

62.01

75.79

57.5

0.068

46.1

CRP (mg/L)

55.00

50.39

58.25

0.707

10